Latest long-term debt for CRY: $3M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), CRY shows a long-term debt of $3M. That compares with $3M in the prior-year period — up 1.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CRY's long-term debt is now $3M (was $3M) — a 1.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Cryolife is outperforming or lagging.
Tracking CRY's long-term debt over time shows whether Cryolife is scaling, shrinking, or reshaping that part of the business. The current reading is $3M That compares with $3M in the prior-year period — up 1.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this long-term debt page, Stockcircle has Cryolife's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $3M) with ownership activity and broader fundamentals.
Cryolife's long-term debt is $3M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.